REVIEW
Published on 22 Jan 2025
Natural killer cell engagers for cancer immunotherapy
doi 10.3389/fonc.2024.1483884
- 532 views
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Research Topics
- Advancements in Drug Development: Exploring Bi-Specific Antibodies as Promising Therapeutic Strategies in Oncology
Advancements in Drug Development: Exploring Bi-Specific Antibodies as Promising Therapeutic Strategies in Oncology
511
Total downloads
2,661
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
MINI REVIEW
Accepted on 14 Jan 2025
Improving CD3 bispecific antibody therapy in solid tumors using combination strategies
doi 10.3389/fonc.2025.1548446
- 102 views
ORIGINAL RESEARCH
Published on 18 Oct 2024
Vδ2 T-cell engagers bivalent for Vδ2-TCR binding provide anti-tumor immunity and support robust Vγ9Vδ2 T-cell expansion
doi 10.3389/fonc.2024.1474007
- 1,120 views
Published in
Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.
Impact
- 2,661Topic views
- 1,588Article views
- 511Article downloads